These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34126015)

  • 1. Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials.
    Sutiwisesak R; Burns TC; Rodriguez M; Warrington AE
    Expert Opin Investig Drugs; 2021 Aug; 30(8):857-876. PubMed ID: 34126015
    [No Abstract]   [Full Text] [Related]  

  • 2. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
    Tepavčević V; Lubetzki C
    Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
    J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.
    Watzlawik JO; Warrington AE; Rodriguez M
    PLoS One; 2013; 8(2):e55149. PubMed ID: 23383310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
    J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
    J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adult oligodendrocyte can participate in remyelination.
    Duncan ID; Radcliff AB; Heidari M; Kidd G; August BK; Wierenga LA
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11807-E11816. PubMed ID: 30487224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging myelin repair agents in preclinical and early clinical development for the treatment of multiple sclerosis.
    Gingele S; Stangel M
    Expert Opin Investig Drugs; 2020 Jun; 29(6):583-594. PubMed ID: 32348161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remyelination in multiple sclerosis.
    Chari DM
    Int Rev Neurobiol; 2007; 79():589-620. PubMed ID: 17531860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remyelination in multiple sclerosis: realizing a long-standing challenge.
    Aharoni R
    Expert Rev Neurother; 2015; 15(12):1369-72. PubMed ID: 26558886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pericytes in Multiple Sclerosis.
    Rivera FJ; Hinrichsen B; Silva ME
    Adv Exp Med Biol; 2019; 1147():167-187. PubMed ID: 31147878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
    Williams JL; Patel JR; Daniels BP; Klein RS
    J Exp Med; 2014 May; 211(5):791-9. PubMed ID: 24733828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin regulatory factor drives remyelination in multiple sclerosis.
    Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
    Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regeneration and repair in multiple sclerosis: the view of experimental pathology.
    Blakemore WF
    J Neurol Sci; 2008 Feb; 265(1-2):1-4. PubMed ID: 17459413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to Remyelination Therapies in Multiple Sclerosis.
    Wooliscroft L; Silbermann E; Cameron M; Bourdette D
    Curr Treat Options Neurol; 2019 Jun; 21(7):34. PubMed ID: 31250211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.